The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

Svensson, EM; Svensson, RJ; te Brake, LHM; Boeree, MJ; Heinrich, N; Konsten, S; Churchyard, G; Dawson, R; Diacon, AH; Kibiki, GS; Minja, LT; Ntingiya, NE; Saone, I; Gillespie, SH; Hoelscher, M; Phillips, PPJ; Simonsson, USH; Aarnoutse, R

Svensson, EM (reprint author), Radboud Univ Nijmegen, Dept Pharm, Med Ctr, POB 9101, NL-6500 HB Nijmegen 864, Netherlands.

CLINICAL INFECTIOUS DISEASES, 2018; 67 (1): 34

Abstract

Background. Tuberculosis remains a huge public health problem and the prolonged treatment duration obstructs effective tuberculosis control. Higher ri......

Full Text Link